APA (7th ed.) Citation

C, G., C, R., D, D., & C, F. (2026). Impact of geriatric covariates on metronomic cyclophosphamide efficacy and tolerance-the CHEMETROLD study. The oncologist, 31(5), . https://doi.org/10.1093/oncolo/oyag130

Chicago Style (17th ed.) Citation

C, Griffe, Ravot C, Dayde D, and Falandry C. "Impact of Geriatric Covariates on Metronomic Cyclophosphamide Efficacy and Tolerance-the CHEMETROLD Study." The Oncologist 31, no. 5 (2026). https://doi.org/10.1093/oncolo/oyag130.

MLA (9th ed.) Citation

C, Griffe, et al. "Impact of Geriatric Covariates on Metronomic Cyclophosphamide Efficacy and Tolerance-the CHEMETROLD Study." The Oncologist, vol. 31, no. 5, 2026, https://doi.org/10.1093/oncolo/oyag130.